Evidence for Distinguishable Treatment Costs among Paranoid Schizophrenia and Schizoaffective Disorder

Open Access

Peer-reviewed

Research Article

Dusan Hirjak ,

* E-mail: dusan.hirjak@med.uni-heidelberg.de

Affiliation Center for Psychosocial Medicine, Department of General Psychiatry, University of Heidelberg, Heidelberg, Germany
⨯
Achim Hochlehnert,

Affiliation Center for Psychosocial Medicine, Department of General Internal Medicine and Psychosomatics, University of Heidelberg, Heidelberg, Germany
⨯
Philipp Arthur Thomann,

Affiliation Center for Psychosocial Medicine, Department of General Psychiatry, University of Heidelberg, Heidelberg, Germany
⨯
Katharina Maria Kubera,

Affiliation Center for Psychosocial Medicine, Department of General Psychiatry, University of Heidelberg, Heidelberg, Germany
⨯
Knut Schnell

Affiliation Center for Psychosocial Medicine, Department of General Psychiatry, University of Heidelberg, Heidelberg, Germany
⨯

Reader Comments (0)

Schizophrenia
Is the Subject Area "Schizophrenia" applicable to this article?

Thanks for your feedback.
Diagnostic medicine
Is the Subject Area "Diagnostic medicine" applicable to this article?

Thanks for your feedback.
Inpatients
Is the Subject Area "Inpatients" applicable to this article?

Thanks for your feedback.
Mental health and psychiatry
Is the Subject Area "Mental health and psychiatry" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Mental health therapies
Is the Subject Area "Mental health therapies" applicable to this article?

Thanks for your feedback.
Germany
Is the Subject Area "Germany" applicable to this article?

Thanks for your feedback.
Health economics
Is the Subject Area "Health economics" applicable to this article?

Thanks for your feedback.